No Increase in Adverse Events Seen With COVID-19 Vaccination After MIS-C
TUESDAY, Jan. 3, 2023 (HealthDay News) — Patients with a history of multisystem inflammatory syndrome in children (MIS-C) do not have an increased risk for serious adverse events after COVID-19 vaccination, according to a study published online Jan. …
Learn MoreUna nueva pastilla para la COVID podría ser mejor que Paxlovid, sugiere un ensayo chino
VIERNES, 30 de diciembre de 2022 (HealthDay News) — Los pacientes con COVID-19 quizá pronto tengan una nueva pastilla antiviral que los proteja de una enfermedad grave.El tratamiento, llamado VV116, funcionó igual que bien que Paxlovid en las persona…
Learn MoreCOVID Vaccine Is Safe for Kids Who Got Rare Complication of COVID Illness
TUESDAY, Jan. 3, 2023 (HealthDay News) — It’s safe for kids to take the COVID-19 vaccine after they’ve suffered a rare complication from a prior COVID infection, a U.S. National Institutes of Health-supported study has concluded.Multisystem inflammat…
Learn MoreEE. UU. requerirá una prueba negativa de COVID para la entrada de los visitantes chinos
JUEVES, 29 de diciembre de 2022 (HealthDay News) — Todos los viajeros que lleguen por avión de China a Estados Unidos pronto tendrán que mostrar una prueba negativa de COVID o enseñar evidencias de recuperación si han tenido una infección reciente co…
Learn MoreCOVID-19 Booster mRNA Dose Increases Antibody Duration
FRIDAY, Dec. 30, 2022 (HealthDay News) — COVID-19 mRNA vaccine boosters increase antibody duration, but do not increase antibody levels, according to a study recently published in the Annals of Allergy, Asthma & Immunology.Samuel M. Ailsworth, from t…
Learn MoreNew COVID Pill May Be Improvement Over Paxlovid, Chinese Trial Suggests
FRIDAY, Dec. 30, 2022 (HealthDay News) — COVID-19 patients could soon have a new antiviral pill they can take to guard against severe disease. The treatment, called VV116, worked as well as Paxlovid in people who were at high risk of severe disease i…
Learn MoreU.S. to Require Negative COVID-19 Test For Chinese Visitor Entry
THURSDAY, Dec. 29, 2022 (HealthDay News) — All travelers flying from China to the United States will soon be required to produce a negative COVID-19 test or show proof of recovery if they have had a recent COVID-19 infection, U.S. health officials an…
Learn MorePonerse los refuerzos contra la COVID ayuda a los anticuerpos a durar más
MIÉRCOLES, 28 de diciembre de 2022 (HealthDay News) — Aunque ponerse una vacuna contra la COVID-19 provee anticuerpos contra el coronavirus, recibir un refuerzo crea una respuesta de anticuerpos de mayor duración, según una investigación reciente.”Es…
Learn MoreChina afloja sus normas para viajar mientras levanta las restricciones por la COVID
MIÉRCOLES, 28 de diciembre de 2022 (HealthDay News) — China planifica reducir algunos de sus estrictos controles por la COVID-19, lo que incluirá permitir que más de sus ciudadanos viajen al extranjero.Durante la pandemia, el país ha limitado los pas…
Learn MoreMolnupiravir Does Not Reduce COVID-19-Related Hospitalization, Death
THURSDAY, Dec. 29, 2022 (HealthDay News) — For high-risk vaccinated adults, molnupiravir plus usual care does not reduce the frequency of COVID-19-associated hospitalizations or deaths, according to a study published online Dec. 22 in The Lancet.Chri…
Learn More